This Friday during the Covid Point, the head of the Department of Epidemiology of the Ministry of Health, Christian García, reported who can be inoculated with the bivalent vaccine against Covid-19 from Next Monday, November 21st.
The bivalent vaccine, annual inoculation which is part of the National Immunization Program (PNI), features the original variant of Wuhan and Omicron, and is focused on the at-risk population, as it provides greater protection against circulating variants.
Thus, according to Garcia’s announcement, Starting next week, all risk groups that are already on the calendar can be vaccinatedi.e. immunosuppressed, health personnel, chronic users aged 12 and over and adults aged 60 and over, who have received at least one dose of reinforcement until 5 June 2022 or who benefited from the primary regime until 31 July 2022.
“Since the annual vaccination against Covid with this bivalent vaccine began, just under a month ago we have managed to almost double the vaccination rate, for which we want to thank the more than 530,000 people who have already come to receive their bivalent vaccine “said the Health Authority.
Vaccination locations can be checked at the Territorial vaccination viewer or on the website or social networks of each municipality.
Review the details of each risk group below.
- Patients with autoimmune diseases receiving biological, small molecule and corticosteroid treatments.
- Patients undergoing solid organ transplantation: heart, lungs, kidneys, liver, pancreas.
- Patients with hematopoietic stem cell transplantation.
- Cancer patients undergoing treatment (radiotherapy, chemotherapy or hormone therapy).
- Dialysis patients (haemo or peritoneum).
- Chronic lung disease.
- Neurological disease.
- Chronic kidney disease.
- Chronic liver disease.
- Metabolic diseases.
- heart disease
- Obesity
- Autoimmune disease.
- Cancer in treatment.
- Immunodeficiencies.
- severe mental illness
- Dialysis patients.
In addition to this, the remaining vaccination schedules with booster doses and fourth doses remain in force:
